GNMSF Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Genmab A/S

Watchlist Manager

Watchlist

Price: 274.5 USD Market Closed

Market Cap: $17.9B

G	Genmab A/S OTC:GNMSF	DK
	Applied DNA Sciences Inc NASDAQ:APDN	US
	Ritchie Bros Auctioneers Inc TSX:RBA	CA
	Namura Shipbuilding Co Ltd OTC:NMRSF	JP
	Beyond Meat Inc NASDAQ:BYND	US
	Wilmar International Ltd SGX:F34	SG
B	Beiersdorf AG MIL:BEI	DE
H	Hartford Financial Services Group Inc XETRA:HFF	US
	Amaroq Minerals Ltd F:72Q	CA

Profitability Summary

Genmab A/S's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

93%

Strong 3Y Average Gross Margin

89%

Gross Margin is Increasing

45% > 93%

Exceptional Operating Margin

33%

Strong 3Y Average Operating Margin

34%

Declining Operating Margin

39% > 33%

Healthy Net Margin

21%

Strong 3Y Average Net Margin

30%

Declining Net Margin

28% > 21%

Exceptional Free Cash Flow Margin

22%

Strong 3Y Average Free Cash Flow Margin

33%

Declining Free Cash Flow Margin

35% > 22%

Positive ROE

15%

Positive 3Y Average ROE

Exceptional 3Y Average ROIC

42%

Declining ROIC

76% > 14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.